SlideShare une entreprise Scribd logo
1  sur  2
Télécharger pour lire hors ligne
II. DESCRIPTION OF A DRUG-RELATED-PROBLEM (DRP)
Version 1
DOCUMENTATION OF PHARMACIST INTERVENTION
Vi-Med®
MEDICATION REVIEW
M3
Diagnosis: ___________________________________
____________________________________________
Related Drug(s): ______________________________
____________________________________________
I.REVIEW
Outpatient
Inpatient
Admission Discharge Treatment process
III. TYPE OF DRP
Unnecessary indication
Non conformity indication
Missing indication
Dosage
Administration mode
Drug side effect
Drug Interaction
Drug monitoring
VI. SUGGEST TO
Doctor  Patient
Nurse Others:
............
VIII. FOLLOW-UP
Accepted Non assessable
Non accepted
Sign: ................................
VII. COMMUNICATION WAY
Face-to-face Phone
Text Others:
Email ………..
IV. DESCRIPTION OF PHARMACIST INTERVENTION (PI)
(References)
Date of review: / / Review N
o
: ___________ Pharmacist: ____________________
PIs N
o
:________________V. TYPE OF PI
Drug discontinuation
Drug switch
Drug addition
Dose increasing
Dose decreasing
Administration modeoptimisation
Drug monitoring optimisation
Name: ______________________________________
Age: ____________________________Male/Female
Weight: __________ kg Height: ___________ cm
Department: ________________ Room: _____________
Doctor: _______________________________________
Date of admission: / / Code:______________
Drug-related-problems Definition/ Description/ Example
 Unnecessary indication
Non indication The patientis not asthmatic and was prescribed asthama drugs.
Duplicate prescription Two drug both containing Paracetamol were prescribed.
An ADR can be prevented instead of being
treated
Levodopa was prescribed for Parkinsonian symptom - the ADR
caused by using valproic acid to treat epilepsy. While this ADR can be
avoided by using other epileptic drugs.
 Non conformity indication
Non conformity of the drug choice compared
to the Drug Formulary
Prescribe a drug not available in the Drug Formulary List.
Non conformity of the drug choice compared
to guidelines
An antihistamine was prescribed for pruritus caused by bilirubin
increasing in biliary obstruction.
Contra-indication The patientis asthmatic and was prescribed with beta-blockers.
Other drug is less costly for the same
effectiveness
Prescibe an inappropriatebrand name of a drug
 Missing indication
Valid indication without drug prescripted
Patient with hypokalaemia was not prescribed with potassium
supplements.
The patient was not given any pre-
medication
Patient taking Methotrexate was not prescribed with Acid folinicin
order to prevent Methotrexate’s ADRs.
Missing drug combination
Only one beta-lactam antibiotic was prescribed without one
Aminoglycoside in severe infections.
 Dosage( Inappropriate dosage according to recommendationsfor the general orspecial patient)
 Subtherapeutic dosage
Levothyroxin dose was too lowin a child with congenital
hypothyroridism.
(Base on age and weight)
 Supratherapeutic dosage Prescribe Paracetamol more than 4g per day.
 Administration mode
Inappropriate route/ drug form Oral medications were prescribed to patient who has vomited.
Inappropriate duration
Prescribe antibiotics for more than 1 week to prevent infection after
surgery.
Inappropriate timing of administration
(compared to meal or other drugs...)
Take Vitamin A before meal.
Take Hydrocortison in the evening.
Take Sulcrafat and Cimetidin at the same time for gastric ulcer.
Incomplete information on the drug regimen
(guidelines for breaking or crushing tablets;
mode of reconstitution…)
Break/chew/crush modified-release drugs.
Do not explain how to use powder for oral suspension.
 Drug side effect
ADR Drug causes ADR at normal dose: NSAID may cause gastric ulcer.
Allergy
Drugs causes allergy not dose-related: Anaphylactic shock by
antibiotics.
Toxicity
Overdosage of the drug causes toxicity in patients: Paracetamol
overdosage causes hepatic necrosis.
 Drug Interaction
Drug – drug interaction
Steroids – NSAIDs combination increases the risk of gastrointestinal
bleeding.
Drug – food/beverage interaction
Cabbage, cauliflower (containing vitamin K) inhibitthe effect of oral
anticoagulants.
Drug – test interaction Third-generation Cephalosporins caused false-positive Coombs tests.
 Drug monitoring(The patient is not suitably or sufficiently followed-up: lab tests, kinetics, clinical treatment...)
 Did not monitor blood potassium level after taking Furosemide.
Version 1

Contenu connexe

Tendances

Digital 2022 Niger (February 2022) v01
Digital 2022 Niger (February 2022) v01Digital 2022 Niger (February 2022) v01
Digital 2022 Niger (February 2022) v01DataReportal
 
Introduction to Social Media Listening
Introduction to Social Media ListeningIntroduction to Social Media Listening
Introduction to Social Media ListeningSocial Deconstructed
 
Digital 2022 Zambia (February 2022) v01
Digital 2022 Zambia (February 2022) v01Digital 2022 Zambia (February 2022) v01
Digital 2022 Zambia (February 2022) v01DataReportal
 
The Art of Social Media Listening
The Art of Social Media ListeningThe Art of Social Media Listening
The Art of Social Media ListeningSusan Chesley Fant
 
Digital 2021 Bulgaria (January 2021) v01
Digital 2021 Bulgaria (January 2021) v01Digital 2021 Bulgaria (January 2021) v01
Digital 2021 Bulgaria (January 2021) v01DataReportal
 
Digital 2021: Essential Facebook Stats for October 2021 v01
Digital 2021: Essential Facebook Stats for October 2021 v01Digital 2021: Essential Facebook Stats for October 2021 v01
Digital 2021: Essential Facebook Stats for October 2021 v01DataReportal
 
Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01
Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01
Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01DataReportal
 
Digital 2022 Switzerland (February 2022) v01
Digital 2022 Switzerland (February 2022) v01Digital 2022 Switzerland (February 2022) v01
Digital 2022 Switzerland (February 2022) v01DataReportal
 
Digital 2022 Morocco (February 2022) v01
Digital 2022 Morocco (February 2022) v01Digital 2022 Morocco (February 2022) v01
Digital 2022 Morocco (February 2022) v01DataReportal
 
Social Media in Market Research
Social Media in Market ResearchSocial Media in Market Research
Social Media in Market ResearchNaresh Mali
 
Digital 2022 Spain (February 2022) v02
Digital 2022 Spain (February 2022) v02Digital 2022 Spain (February 2022) v02
Digital 2022 Spain (February 2022) v02DataReportal
 
Digital 2022 United States of America (February 2022) v02
Digital 2022 United States of America (February 2022) v02Digital 2022 United States of America (February 2022) v02
Digital 2022 United States of America (February 2022) v02DataReportal
 
Geriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients PharmacokineticsGeriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients PharmacokineticsAreej Abu Hanieh
 
Global Digital 2022 Report
Global Digital 2022 ReportGlobal Digital 2022 Report
Global Digital 2022 ReportMarketingTrips
 
Digital 2022: Essential Facebook Stats for Q1 2022 v01
Digital 2022: Essential Facebook Stats for Q1 2022 v01Digital 2022: Essential Facebook Stats for Q1 2022 v01
Digital 2022: Essential Facebook Stats for Q1 2022 v01DataReportal
 
Digital 2022 Kuwait (February 2022) v01
Digital 2022 Kuwait (February 2022) v01Digital 2022 Kuwait (February 2022) v01
Digital 2022 Kuwait (February 2022) v01DataReportal
 
Digital 2022 United Kingdom (February 2022) v02
Digital 2022 United Kingdom (February 2022) v02Digital 2022 United Kingdom (February 2022) v02
Digital 2022 United Kingdom (February 2022) v02DataReportal
 
Digital 2022 Central African Republic (February 2022) v01
Digital 2022 Central African Republic (February 2022) v01Digital 2022 Central African Republic (February 2022) v01
Digital 2022 Central African Republic (February 2022) v01DataReportal
 

Tendances (20)

Digital 2022 Niger (February 2022) v01
Digital 2022 Niger (February 2022) v01Digital 2022 Niger (February 2022) v01
Digital 2022 Niger (February 2022) v01
 
Introduction to Social Media Listening
Introduction to Social Media ListeningIntroduction to Social Media Listening
Introduction to Social Media Listening
 
Digital 2022 Zambia (February 2022) v01
Digital 2022 Zambia (February 2022) v01Digital 2022 Zambia (February 2022) v01
Digital 2022 Zambia (February 2022) v01
 
The Art of Social Media Listening
The Art of Social Media ListeningThe Art of Social Media Listening
The Art of Social Media Listening
 
Digital 2021 Bulgaria (January 2021) v01
Digital 2021 Bulgaria (January 2021) v01Digital 2021 Bulgaria (January 2021) v01
Digital 2021 Bulgaria (January 2021) v01
 
Digital 2021: Essential Facebook Stats for October 2021 v01
Digital 2021: Essential Facebook Stats for October 2021 v01Digital 2021: Essential Facebook Stats for October 2021 v01
Digital 2021: Essential Facebook Stats for October 2021 v01
 
Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01
Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01
Digital 2022: Essential Facebook Messenger Stats for Q1 2022 v01
 
Digital 2022 Switzerland (February 2022) v01
Digital 2022 Switzerland (February 2022) v01Digital 2022 Switzerland (February 2022) v01
Digital 2022 Switzerland (February 2022) v01
 
Digital 2022 Morocco (February 2022) v01
Digital 2022 Morocco (February 2022) v01Digital 2022 Morocco (February 2022) v01
Digital 2022 Morocco (February 2022) v01
 
Social Media in Market Research
Social Media in Market ResearchSocial Media in Market Research
Social Media in Market Research
 
Digital 2022 Spain (February 2022) v02
Digital 2022 Spain (February 2022) v02Digital 2022 Spain (February 2022) v02
Digital 2022 Spain (February 2022) v02
 
Digital 2022 United States of America (February 2022) v02
Digital 2022 United States of America (February 2022) v02Digital 2022 United States of America (February 2022) v02
Digital 2022 United States of America (February 2022) v02
 
Geriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients PharmacokineticsGeriatric,obese and pediatric patients Pharmacokinetics
Geriatric,obese and pediatric patients Pharmacokinetics
 
TDM of Lithium.pdf
TDM of Lithium.pdfTDM of Lithium.pdf
TDM of Lithium.pdf
 
Global Digital 2022 Report
Global Digital 2022 ReportGlobal Digital 2022 Report
Global Digital 2022 Report
 
Digital 2022: Essential Facebook Stats for Q1 2022 v01
Digital 2022: Essential Facebook Stats for Q1 2022 v01Digital 2022: Essential Facebook Stats for Q1 2022 v01
Digital 2022: Essential Facebook Stats for Q1 2022 v01
 
Mundo digital España 2022
Mundo digital España 2022Mundo digital España 2022
Mundo digital España 2022
 
Digital 2022 Kuwait (February 2022) v01
Digital 2022 Kuwait (February 2022) v01Digital 2022 Kuwait (February 2022) v01
Digital 2022 Kuwait (February 2022) v01
 
Digital 2022 United Kingdom (February 2022) v02
Digital 2022 United Kingdom (February 2022) v02Digital 2022 United Kingdom (February 2022) v02
Digital 2022 United Kingdom (February 2022) v02
 
Digital 2022 Central African Republic (February 2022) v01
Digital 2022 Central African Republic (February 2022) v01Digital 2022 Central African Republic (February 2022) v01
Digital 2022 Central African Republic (February 2022) v01
 

Similaire à Drug-related-problem documentation form

Similaire à Drug-related-problem documentation form (20)

Medication errors Dr-Z Pharmacy Practice Lecture
Medication errors Dr-Z Pharmacy Practice LectureMedication errors Dr-Z Pharmacy Practice Lecture
Medication errors Dr-Z Pharmacy Practice Lecture
 
Cassualty assesment of adr
Cassualty assesment of adrCassualty assesment of adr
Cassualty assesment of adr
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Medication error
Medication errorMedication error
Medication error
 
Medication safety 311.ppt
Medication safety 311.pptMedication safety 311.ppt
Medication safety 311.ppt
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
Md new
Md newMd new
Md new
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
CLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptxCLINICAL PHARMACY.pptx
CLINICAL PHARMACY.pptx
 
Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Managing medicine safety
Managing medicine safetyManaging medicine safety
Managing medicine safety
 
Pharmacotherapeutics-UNIT1.pptx
Pharmacotherapeutics-UNIT1.pptxPharmacotherapeutics-UNIT1.pptx
Pharmacotherapeutics-UNIT1.pptx
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
 
Drug intolerance
Drug intoleranceDrug intolerance
Drug intolerance
 
Medications
MedicationsMedications
Medications
 
Adverse drug reaction.pptx
Adverse drug reaction.pptxAdverse drug reaction.pptx
Adverse drug reaction.pptx
 
Unit 4 pharmacovigilance (6hrs) march 13 2021
Unit 4 pharmacovigilance (6hrs) march 13 2021Unit 4 pharmacovigilance (6hrs) march 13 2021
Unit 4 pharmacovigilance (6hrs) march 13 2021
 
Clinical pharmacology
Clinical pharmacologyClinical pharmacology
Clinical pharmacology
 
Identifying DRP's In Community Pharmacy Setting
Identifying DRP's In Community Pharmacy SettingIdentifying DRP's In Community Pharmacy Setting
Identifying DRP's In Community Pharmacy Setting
 

Plus de HA VO THI

Development and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication reviewDevelopment and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication reviewHA VO THI
 
Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ HA VO THI
 
Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo HA VO THI
 
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)HA VO THI
 
English for pharmacist
English for pharmacistEnglish for pharmacist
English for pharmacistHA VO THI
 
Độc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thưĐộc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thưHA VO THI
 
Quản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thưQuản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thưHA VO THI
 
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2HA VO THI
 
Vi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English versionVi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English versionHA VO THI
 
Vi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English versionVi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English versionHA VO THI
 
Quản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinhQuản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinhHA VO THI
 
Poster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue CityPoster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue CityHA VO THI
 
Poster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication reviewPoster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication reviewHA VO THI
 
Thông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại HuếThông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại HuếHA VO THI
 
Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010HA VO THI
 
Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”HA VO THI
 
Bảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵBảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵHA VO THI
 
Bảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinhBảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinhHA VO THI
 
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017HA VO THI
 
Quản lý thuốc LASA-BV ĐH Y Dược Huế
Quản lý thuốc LASA-BV ĐH Y Dược HuếQuản lý thuốc LASA-BV ĐH Y Dược Huế
Quản lý thuốc LASA-BV ĐH Y Dược HuếHA VO THI
 

Plus de HA VO THI (20)

Development and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication reviewDevelopment and validation of the Vi-Med ® tool for medication review
Development and validation of the Vi-Med ® tool for medication review
 
Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ Bảng tra tương hợp - tương kỵ
Bảng tra tương hợp - tương kỵ
 
Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo Bảng dị ứng kháng sinh chéo
Bảng dị ứng kháng sinh chéo
 
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
Hỏi: Diazepam IV có thể bơm trực tràng được không ? (đính chính)
 
English for pharmacist
English for pharmacistEnglish for pharmacist
English for pharmacist
 
Độc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thưĐộc tính trên da của thuốc trị ung thư
Độc tính trên da của thuốc trị ung thư
 
Quản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thưQuản lý ADR hóa trị liệu ung thư
Quản lý ADR hóa trị liệu ung thư
 
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
Công cụ Vi-Med hỗ trợ Xem xét sử dụng thuốc - Form 2
 
Vi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English versionVi-Med tool for medication review - Form 2 - English version
Vi-Med tool for medication review - Form 2 - English version
 
Vi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English versionVi-Med tool for medication review - Form 1 - English version
Vi-Med tool for medication review - Form 1 - English version
 
Quản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinhQuản lý sử dụng kháng sinh
Quản lý sử dụng kháng sinh
 
Poster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue CityPoster - Counseling activities of drug use at community pharmacy in Hue City
Poster - Counseling activities of drug use at community pharmacy in Hue City
 
Poster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication reviewPoster- The Vi-Med tool for medication review
Poster- The Vi-Med tool for medication review
 
Thông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại HuếThông báo tuyển sinh thạc sĩ DL-DLS tại Huế
Thông báo tuyển sinh thạc sĩ DL-DLS tại Huế
 
Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010Bệnh động mạch chi dưới - khuyến cáo 2010
Bệnh động mạch chi dưới - khuyến cáo 2010
 
Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”Poster “Quản lý thuốc nguy cơ cao”
Poster “Quản lý thuốc nguy cơ cao”
 
Bảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵBảng tra tương hợp-tương kỵ
Bảng tra tương hợp-tương kỵ
 
Bảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinhBảng dị ứng chéo kháng sinh
Bảng dị ứng chéo kháng sinh
 
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
Danh mục thuốc LASA-BV ĐH Y Dược Huế 2017
 
Quản lý thuốc LASA-BV ĐH Y Dược Huế
Quản lý thuốc LASA-BV ĐH Y Dược HuếQuản lý thuốc LASA-BV ĐH Y Dược Huế
Quản lý thuốc LASA-BV ĐH Y Dược Huế
 

Dernier

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 

Dernier (20)

Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 

Drug-related-problem documentation form

  • 1. II. DESCRIPTION OF A DRUG-RELATED-PROBLEM (DRP) Version 1 DOCUMENTATION OF PHARMACIST INTERVENTION Vi-Med® MEDICATION REVIEW M3 Diagnosis: ___________________________________ ____________________________________________ Related Drug(s): ______________________________ ____________________________________________ I.REVIEW Outpatient Inpatient Admission Discharge Treatment process III. TYPE OF DRP Unnecessary indication Non conformity indication Missing indication Dosage Administration mode Drug side effect Drug Interaction Drug monitoring VI. SUGGEST TO Doctor  Patient Nurse Others: ............ VIII. FOLLOW-UP Accepted Non assessable Non accepted Sign: ................................ VII. COMMUNICATION WAY Face-to-face Phone Text Others: Email ……….. IV. DESCRIPTION OF PHARMACIST INTERVENTION (PI) (References) Date of review: / / Review N o : ___________ Pharmacist: ____________________ PIs N o :________________V. TYPE OF PI Drug discontinuation Drug switch Drug addition Dose increasing Dose decreasing Administration modeoptimisation Drug monitoring optimisation Name: ______________________________________ Age: ____________________________Male/Female Weight: __________ kg Height: ___________ cm Department: ________________ Room: _____________ Doctor: _______________________________________ Date of admission: / / Code:______________
  • 2. Drug-related-problems Definition/ Description/ Example  Unnecessary indication Non indication The patientis not asthmatic and was prescribed asthama drugs. Duplicate prescription Two drug both containing Paracetamol were prescribed. An ADR can be prevented instead of being treated Levodopa was prescribed for Parkinsonian symptom - the ADR caused by using valproic acid to treat epilepsy. While this ADR can be avoided by using other epileptic drugs.  Non conformity indication Non conformity of the drug choice compared to the Drug Formulary Prescribe a drug not available in the Drug Formulary List. Non conformity of the drug choice compared to guidelines An antihistamine was prescribed for pruritus caused by bilirubin increasing in biliary obstruction. Contra-indication The patientis asthmatic and was prescribed with beta-blockers. Other drug is less costly for the same effectiveness Prescibe an inappropriatebrand name of a drug  Missing indication Valid indication without drug prescripted Patient with hypokalaemia was not prescribed with potassium supplements. The patient was not given any pre- medication Patient taking Methotrexate was not prescribed with Acid folinicin order to prevent Methotrexate’s ADRs. Missing drug combination Only one beta-lactam antibiotic was prescribed without one Aminoglycoside in severe infections.  Dosage( Inappropriate dosage according to recommendationsfor the general orspecial patient)  Subtherapeutic dosage Levothyroxin dose was too lowin a child with congenital hypothyroridism. (Base on age and weight)  Supratherapeutic dosage Prescribe Paracetamol more than 4g per day.  Administration mode Inappropriate route/ drug form Oral medications were prescribed to patient who has vomited. Inappropriate duration Prescribe antibiotics for more than 1 week to prevent infection after surgery. Inappropriate timing of administration (compared to meal or other drugs...) Take Vitamin A before meal. Take Hydrocortison in the evening. Take Sulcrafat and Cimetidin at the same time for gastric ulcer. Incomplete information on the drug regimen (guidelines for breaking or crushing tablets; mode of reconstitution…) Break/chew/crush modified-release drugs. Do not explain how to use powder for oral suspension.  Drug side effect ADR Drug causes ADR at normal dose: NSAID may cause gastric ulcer. Allergy Drugs causes allergy not dose-related: Anaphylactic shock by antibiotics. Toxicity Overdosage of the drug causes toxicity in patients: Paracetamol overdosage causes hepatic necrosis.  Drug Interaction Drug – drug interaction Steroids – NSAIDs combination increases the risk of gastrointestinal bleeding. Drug – food/beverage interaction Cabbage, cauliflower (containing vitamin K) inhibitthe effect of oral anticoagulants. Drug – test interaction Third-generation Cephalosporins caused false-positive Coombs tests.  Drug monitoring(The patient is not suitably or sufficiently followed-up: lab tests, kinetics, clinical treatment...)  Did not monitor blood potassium level after taking Furosemide. Version 1